Saltini C, Winestock K, Kirby M,et al. Maintenance of alveolitis in pat ient s with chronic beryllium disease by beryllium-specific helper T cells[J].N En gl J Med, 1989,320:1103-1109.
[14]
Tinkle SS, Kittle LA, Schumacher B,et al. Beryllium induces IL-2 and IF N-β in berylliosis[J]. J Immunol, 1997,158:518-526.
[15]
Bost TW. Alveolar macrophages from patients with beryllium disease and sarc oidosis express increased levels of mRNA for tumor necrosis factor-α and interl eukin-6 but not interleukin- 1β[J]. Am J Respir Cell Mol Biol, 1994,10:506 .
[16]
Tinkle SS, Newman LS. Beryllium-stimulated release of tumor necrosis fa ctor -β, interleukin-6, and their soluble receptors in chronic beryllium disease[J ].Am J Respir Crit Care Med,1997,156:1884-1891.
[17]
Tinkle SS, Kittle LA, Newman LS. Partial IL-10 inhibition of the cell-m edia ted immune response in chronic beryllium disease[J].J Immunol, 1999,6:2747-27 53.
[18]
Galbraith GM, Pandey JP, Schmidt MG, et al. Tumor necrosis factor alpha gen e expression in human monocytic THP-1 cells exposed to beryllium[J]. Arch Env iron Health,1996,51:29-33.
[19]
Victoratos P, Yiangou M, Avramidis N, et al. Regulation of cytokine gen e expression by adjuvants in vivo[J]. Clin Exp Immunol, 1997, 109:569-578.
[20]
Misra UK, Gawdi G, Pizzo SV, et al. Exposure of cultured murine periton eal macrophages to low concentrations of beryllium induces increases in intracellula r calcium concentrations and stimulated DNA synthesis[J]. J Leukocyte Biol, 1 999,65:786-791.
[21]
Deodhar SD.A study of the immunologic aspects of chronic berylliosis[J ].Chest,1973,63(3):309.
